hsa-mir-4730: Hsa-mir-4730 is a microRNA that has been studied in relation to its regulatory effects on genes [PMC9867723]. Analyses have shown that hsa-mir-4730, along with hsa-miR-155-5p and hsa-miR-762, affects a significant number of genes [PMC9867723]. In Parkinson's disease (PD) samples, the expression of hsa-mir-4730 is significantly decreased at various time points [PMC9867723]. The fold changes in expression between PD and healthy control samples range from -0.46 to -0.83 for hsa-mir-4730 [PMC9867723]. In a prediction study, 11 out of 12 CIR-miRNAs were found to be associated with enriched GO pathways, except for hsa-mir-4730 [PMC9318750]. Conversely, the expression of microRNAs such as hsa-miR30a5p and hasmiR4284 decreases in response to Jurkat cells derived exosomes [PMC9525320]. The TaqMan MicroRNA Assay was used to amplify the cDNA of mature microRNAs including hasmiR4730 [PMC4583533]. Additionally, TaqMan MicroRNA Assays were used for the primer sets in gene expression assays involving high mobility group A1 (HMGA1) and βactin genes [PMC9106373].